Skip to content
The Nexus
BUSINESSAug 12 · 11:21 UTCWTOP DCWTOP Staff

Milestone Pharmaceuticals: Q2 Earnings Snapshot

Milestone Pharmaceuticals Inc. reported a loss of $28.6 million and 21 cents per share for its second quarter, missing Wall Street expectations. The company also posted revenue of $559,000, which fell short of the three-analyst forecast of $800,000.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Milestone PharmaceuticalsorganizationMISTorganizationZacks Investment ResearchorganizationMontrealplace$28.6 milliontopicbiotechnologytopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting

Milestone Pharmaceuticals: Q2 Earnings Snapshot · The Nexus